Abstract:AIMS Endothelial cell (EC) homeostasis plays an important role in normal physiological cardiac functions, and its dysfunction significantly influences pathological cardiac remodeling after myocardial infarction (MI). It has been shown that the sphingosine 1-phospahte receptor 1 (S1pr1) was highly expressed in ECs and played an important role in maintaining endothelial functions. We thus hypothesized that the endothelial S1pr1 might be involved in post-MI cardiac remodeling. METHODS AND RESULTS Our study showed that the specific loss of endothelial S1pr1 exacerbated post-MI cardiac remodeling and worsened cardiac dysfunction. We found that the loss of endothelial S1pr1 significantly reduced Ly6clow macrophage accumulation, which is critical for the resolution of inflammation and cardiac healing following MI. The reduced reparative macrophages in post-MI myocardium contributed to the detrimental effects of endothelial S1pr1 deficiency on post-MI cardiac remodeling. Further investigations showed that the loss of endothelial S1pr1 reduced Ly6clow macrophage proliferation, while the pharmacological activation of S1pr1 enhanced Ly6clow macrophage proliferation and thereby ameliorated cardiac remodeling after MI. A mechanism study showed that S1P/S1pr1 activated the ERK signaling pathway and enhanced colony stimulating factor 1 (CSF1) expression, which promoted Ly6clow macrophage proliferation in a cell-contact manner. The blockade of CSF1 signaling reversed the enhancing effect of S1pr1 activation on Ly6clow macrophage proliferation and worsened post-MI cardiac remodeling. CONCLUSIONS This study reveals that cardiac microvascular endothelium promotes reparative macrophage proliferation in injured hearts via the S1P/S1PR1/ERK/CSF1 pathway and thus ameliorates post-MI adverse cardiac remodeling. TRANSLATIONAL PERSPECTIVE This study highlights the importance of the local vascular microenvironment in orchestrating tissue inflammation and remodeling by regulating self-replenishment of tissue local reparative macrophages. Our studies demonstrate that ECs tightly control post-MI reparative Mo/Mϕ proliferation via the S1P/S1PR1/CSF1 pathway in a cell-contact manner. This implies that a feasible modulation of vascular niche signals might provide a promising target to resolve excessive inflammation and to ameliorate adverse cardiac remodeling after MI.

AMPK and Cardiac Remodelling

Mechanisms Contributing to Cardiac Remodelling

Cardiac contractility modulation ameliorates myocardial metabolic remodeling in a rabbit model of chronic heart failure through activation of AMPK and PPAR-α pathway

Targeting the energy guardian AMPK: another avenue for treating cardiomyopathy?

Vascular Endothelial S1pr1 Ameliorates Adverse Cardiac Remodelling Via Stimulating Reparative Macrophage Proliferation after Myocardial Infarction.

Endothelial S1pr1 Regulates Pressure Overload‐induced Cardiac Remodelling Through AKT‐eNOS Pathway

Fitness Or Fatness: The Debate Continues For Amp-Activated Protein Kinase In Heart Function

Abstract 17221: AMPK Regulation of Microtubule Dynamics in Cardiac Hypertrophy

Regulation of Cardiac Remodeling by Cardiac Na+/K+-Atpase Isoforms

Research Progress on the Interaction Between Autophagy and Energy Homeostasis in Cardiac Remodeling

Cardiac Remodeling: Novel Pathophysiological Mechanisms and Therapeutic Strategies

Metabolic Alterations and Therapeutic Targets of Pathological Cardiac Remodeling

AMP-activated Protein Kinase Sparks the Fire of Cardioprotection Against Myocardial Ischemia and Cardiac Ageing.

AMPK blunts chronic heart failure by inhibiting autophagy.

AMP-activated Protein Kinase Modulates Cardiac Autophagy in Diabetic Cardiomyopathy

Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges

AMPK Attenuates Microtubule Proliferation in Cardiac Hypertrophy.

Activated FMS‐like Tyrosine Kinase 3 Ameliorates Angiotensin II‐induced Cardiac Remodelling

AMPKα1 deletion in myofibroblasts exacerbates post-myocardial infarction fibrosis by a connexin 43 mechanism

Beta-adrenoceptor Signaling Pathways Mediate Cardiac Pathological Remodeling.

The role of AMP-activated protein kinase in the cardiovascular system